KKR Genetic Disorder L.P.'s Net Worth

$1.29 Billion

Estimate Recalculated Feb 21, 2024 04:08PM EST

Who is KKR Genetic Disorder L.P.?

KKR Genetic Disorder L.P. has an estimated net worth of $1.29 Billion. This is based on reported shares in BridgeBio Pharma, Inc..

SEC CIK

KKR Genetic Disorder L.P.'s CIK is 0001780408

Past Insider Trading and Trends

2019 was KKR Genetic Disorder L.P.'s most active year for acquiring shares with 2 total transactions. KKR Genetic Disorder L.P.'s most active month to acquire stocks was the month of June. 2019 was KKR Genetic Disorder L.P.'s most active year for disposing of shares, totalling 3 transactions. KKR Genetic Disorder L.P.'s most active month to dispose stocks was the month of June. 2019 saw KKR Genetic Disorder L.P. paying a total of $45,000,700.00 for 36,900,661 shares, this is the most they've acquired in one year. In 2021 KKR Genetic Disorder L.P. cashed out on 3,450,000 shares for a total of $208,617,360.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BridgeBio Pharma, Inc. (BBIO) Snapshot price: $33.78

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-10.00%
-3.45M
$60.47
-$208,617,360.00
31.06M
Feb 17
Form 4
-6.48%
-2.39M
$33.39
-$79,791,749.10
34.51M
May 28
Form 4
36.9M
$17.00
36.9M
Jul 1
Form 3
0
0
No matching records found